Government ❯ Health Policy

Regulatory Agencies

FDA Anvisa ANMAT Drug Regulation Health Regulations Drug Approval Health Recommendations ANVISA Cofepris Centers for Disease Control and Prevention

OPS Opens Regional Procurement to Argentine Drugmakers With First Major Vaccine Deal

Talks now target export quotas alongside streamlined ANMAT recognition across participating countries.

Paris Region Suspends Four Inpatient Child Psychiatry Units at Fondation Vallée From Feb. 27

Brazil Weighs Tirzepatide Access: New Bill Seeks Farmácia Popular Coverage as Patent‑Break Push Advances

Japan Orders Reforms at Tokyo Regenerative Clinic Over Unapproved Drug Mixing and Unreported Harms

Bhattacharya Poised to Lead CDC as Acting Director After Year of RFK Jr. Upheaval

Mexican Court Revives Denosumab Patent, Extends Amgen Exclusivity to 2027

FDA Rejects Filing of Moderna’s mRNA Flu Vaccine Over Comparator Dispute

24 Families File Paris Complaint in Infant-Formula Toxin Scandal

Peru and Mexico Order Precautionary Recall of Alula Gold Infant Formulas Over Toxin Alert

Brazil Advances Injectable HIV PrEP Rollout, Explores Local Production After Fiocruz–Gilead Memorandum

HHS Opens Review of Cellphone Radiation Risks as FDA Pulls Old Safety Pages

Kennedy Appoints Two OB-GYNs to CDC Vaccine Panel, Extending Overhaul of ACIP

Brazil Authorizes First Human Trial of UFRJ’s Polilaminina for Acute Spinal Cord Injury

Investigation Finds Banned Insulin Still Dispensed in Peru Despite Recall Order

Brazil’s Superior Court of Justice Rejects Semaglutide Patent Extension, Paving Way for 2026 Generics

Families Stage Twin Marches Over Contaminated Fentanyl Deaths as Federal Probe Deepens

FDA Opens Safety Review of Infant RSV Antibody Drugs Beyfortus and Enflonsia

Brazil Approves Butantan’s Single‑Dose Dengue Vaccine, With SUS Rollout Set for January

FDA Installs Tracy Beth Hoeg as Acting CDER Director as Pazdur Files Retirement

Brazil Approves First Single-Dose Dengue Vaccine